• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Streamex Corp. Provides May 2026 Shareholder Update

    5/11/26 8:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $STEX alert in real time by email

    WINTER PARK, Fla., May 11, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company focused on the tokenization of commodity real-world assets, today re-released the following update to shareholders outlining recent operational progress, platform development, and the Company's strategic outlook.

    Dear Shareholders,

    The past quarter has been a period of foundational progress. Following our April update, we want to share where the business stands today and how we are thinking about the opportunity ahead.

    The Opportunity

    Industry estimates project the market for tokenized real-world assets at roughly $16 trillion by 2030. The shift from legacy financial rails to blockchain-based settlement, custody, and distribution is one of the largest infrastructure transitions underway in finance, and commodities, a multi-trillion-dollar global market, are among the asset classes best suited to move on-chain. Streamex was built specifically for this opportunity, and we believe we are well-positioned to lead it.

    Streamex as a Platform

    The Streamex platform is an end-to-end ecosystem for tokenized commodities, operating as both the technology infrastructure and the issuer of the products that run on it. The platform is highly scalable and powers issuance, custody integration, compliance, and on-chain settlement; Streamex gives investors direct exposure to commodity-backed, yield-bearing assets. Owning the full stack means every product launch validates and strengthens the platform that supports the next, ultimately creating a multifaceted growth strategy for the Streamex shareholders.

    GLDY is the first product and the proof point. NAV continues to track the gold price, the first dividend has been paid to holders, and the first attestation is in process. The infrastructure that supports GLDY is live, auditable, and proven, and the foundation that every subsequent product will be built on. We expect the marginal cost and time to launch each subsequent product to be meaningfully lower than the cost of issuing the first.

    Our work ahead is twofold. First, continue to grow GLDY by expanding its use cases, distribution, and AUM. Second, extend the same platform across the broader commodities universe, including silver, copper, oil and gas, royalties, streams, and beyond. Each additional product will compound the value of the platform, and the roster of issuable commodity-backed assets is long.

    Market Activity

    We want to address recent market activity directly. STEX has experienced downward price pressure in recent months, and we are aware that some shareholders expected GLDY AUM to grow on a faster timeline. We've proven that the model and product works, but we hit some early operational hiccups that may have slowed initial growth. These included an integration issue with our KYC vendor that delayed onboarding of some investors. That issue has been resolved, and backlogged signups are now being worked on by a new dedicated sales and service team. The pipeline continues to grow, and we now expect to see steady growth in GLDY's AUM in the coming months.

    Distribution & Increased Functionality

    The most important operational work currently underway is the expansion of our secondary trading and distribution infrastructure, which is what will drive the next phase of AUM growth. SWAP-dealer relationships have been started, that will further simplify the custody and purchase pathway for ETFs. Instant liquidity rails are being put in place for instant minting and redemption of GLDY which means instant settlement, or T+0. This is supported by relationships with leading institutional market makers and decentralized liquidity venues. Alongside that, we are continuing to build out secondary-trading infrastructure for GLDY, including a permissioned secondary-trading venue, to support liquidity, price discovery, and broader access alongside traditional channels. This is critical for rapid scaling as well as a potential additional revenue source.

    With major launch issues solved and behind us, we are concurrently extending GLDY into channels that have not historically had access to tokenized commodity products. Integrations are underway to bring GLDY to wealth-manager distribution platforms and to retirement-account custodians, and we are progressing primary-issuance and secondary-trading integrations with established institutional trading venues. We are also developing a non-security version of GLDY designed to broaden the product's distribution reach. Beyond GLDY, the platform is being prepared to support additional tokenized commodity launches.

    We are also strengthening the team that drives distribution. We are in the process of hiring a Head of Distribution and are continuing to build out our dedicated product sales team focused on GLDY and future launches.

    Financials

    As reflected in our most recent 10-Q, we continue to be responsible stewards of capital. Even as we scale with key hires, cash spend remains careful, and liquid assets and securities on balance sheet exceeded $40 million at quarter end. Co-Founders Morgan and Henry have forgone equity grants for this year to reduce dilution. The company is well capitalized to execute on the milestones set for 2026, 2027, and beyond.

    The Road Ahead

    What makes Streamex compelling is scalable platform with a working first product, demand from institutional and accredited investors, sufficient capital, a strong and growing team, and a position in one of the largest markets being moved on-chain. GLDY has shown the model works. The opportunity in front of us is to compound that proof across the commodities universe, and we are building toward exactly that.

    About Streamex Corp.

    Streamex Corp. (NASDAQ:STEX) is a technology and infrastructure company focused on the tokenization and digitalization of commodity real-world assets. Streamex delivers institutional-grade solutions that bridge traditional finance and blockchain-enabled markets through secure, regulated, and yield-bearing financial instruments.

    For more information, visit www.streamex.com.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding Streamex's business strategy, future growth, product development, AUM growth, platform expansion, distribution initiatives, and liquidity initiatives. These statements are based on current expectations and assumptions that are subject to risks and uncertainties, many of which are beyond Streamex's control, and actual results may differ materially. Factors that could cause such differences include, among others, market conditions, regulatory developments, and macroeconomic factors affecting digital asset markets. A discussion of these and other factors, including risks and uncertainties with respect to Streamex, is set forth in Streamex's filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K, as may be supplemented or updated by Streamex's Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, as well as discussions of potential risks, uncertainties, and other important factors included in other filings by Streamex from time to time. Streamex undertakes no obligation to update or revise any forward-looking statements except as required by applicable law.

    Contacts

    Streamex Press & Investor Relations

    Adele Carey – Alliance Advisors Investor Relations

    IR@streamex.com | acarey@allianceadvisors.com

    Henry McPhie

    Chief Executive Officer, Streamex Corp.

    www.streamex.com | X.com/streamex



    Primary Logo

    Get the next $STEX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $STEX

    DatePrice TargetRatingAnalyst
    11/25/2025$12.00Buy
    Needham
    More analyst ratings

    $STEX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Interim Executive Chairman Lekstrom Morgan Lee bought $49,750 worth of shares (50,000 units at $0.99) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    6/15/26 1:21:02 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: Interim Executive Chairman Lekstrom Morgan Lee bought $147,289 worth of shares (47,000 units at $3.13) (SEC Form 4)

    4/A - Streamex Corp. (0001530766) (Issuer)

    5/28/26 9:43:32 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Interim Executive Chairman Lekstrom Morgan Lee bought $49,980 worth of shares (34,000 units at $1.47) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    5/28/26 2:33:28 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Matthews Shawn was granted 100,000 shares, increasing direct ownership by 100% to 200,000 units (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    7/10/26 5:00:04 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Gopaul Kevin Roy was granted 100,000 shares, increasing direct ownership by 100% to 200,000 units (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    7/10/26 5:00:03 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Interim Executive Chairman Lekstrom Morgan Lee bought $49,750 worth of shares (50,000 units at $0.99) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    6/15/26 1:21:02 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Needham initiated coverage on Streamex Exchange Corporation with a new price target

    Needham initiated coverage of Streamex Exchange Corporation with a rating of Buy and set a new price target of $12.00

    11/25/25 7:59:34 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Streamex Corp. Announces GLDY Now Available for Custody by Inspira Financial, Unlocking Yield-Bearing Gold Exposure for Traditional Finance Investors

    Highlights GLDY Class B shares are now available for custody by Inspira Financial, a qualified custodian under the SEC's Custody Rule. Institutional investors, RIA’s, wealth managers, and advisors who hold client assets within Inspira can now access GLDY through infrastructure they already use.Inspira Financial holds over $63 billion in assets across more than 8 million accounts and has serviced over 1,500 funds. As one of the largest directed custodians in the country, Inspira gives GLDY access to an established institutional custody network with deep reach into the traditional finance capital market, representing a significant step-change in GLDY's addressable distribution.Inspira is the

    7/21/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Announces June 2026 Yield Dividend Distribution for GLDY

    WINTER PARK, Fla., July 17, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company building the tokenization ecosystem for all real-world assets beginning with commodities, today announced the distribution of the fourth yield payment for GLDY, its yield-bearing gold asset, occurred on July 17th, 2026. The distribution covers the period from June 1st through June 30th, 2026. Yield Distribution Details GLDY's real-world yield is generated through Streamex's institutional gold leasing program, with proceeds from the program distributed to GLDY holders in the form of additional GLDY tokens monthly. Each GLDY token is currently earning an ann

    7/17/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Announces 10,000,000 Share Repurchase Program

    WINTER PARK, Fla., July 07, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology and infrastructure company focused on the tokenization of commodity real-world assets, today announced that its board of directors has authorized a new share repurchase program, under which the Company may repurchase, from time to time, up to an aggregate of 10,000,000 shares of the Company’s common stock, par value $0.001 per share, at a price per share up to $2.00, over the next 12 months. Morgan Lekstrom, Executive Chairman of Streamex, said:"The board’s authorization of this repurchase program is a direct expression of our confidence in Streamex’s value and our

    7/7/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    SEC Filings

    View All

    Streamex Corp. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

    8-K - Streamex Corp. (0001530766) (Filer)

    7/13/26 5:19:19 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Streamex Corp. (0001530766) (Filer)

    5/28/26 4:05:31 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Streamex Corp. (0001530766) (Filer)

    5/27/26 6:05:10 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    Leadership Updates

    Live Leadership Updates

    View All

    Streamex Corp. Appoints Former Microsoft and PayPal Lead Product Designer Kori Handy as Vice President of Product and Design

    WINTER PARK, Fla., May 26, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company building the tokenization ecosystem for all real-world assets beginning with commodities, today announced the appointment of Kori Handy as Vice President of Product and Design. Kori brings 18 years of experience scaling fintech and SaaS platforms from zero to $2B+ in assets under management and more than 200 million users, and joins Streamex at a pivotal moment in the Company's growth trajectory. Highlights Kori brings nearly two decades of product, design, and startup leadership experience building fintech and SaaS platforms used by more than 200 million p

    5/26/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Appoints Christine Plummer, Former Global Controller at Coinbase and Managing Director at Morgan Stanley, as Chief Financial Officer

    WINTER PARK, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology and infrastructure company focused on the tokenization of commodity real-world assets, today announced the appointment of Christine Plummer, former Global Controller at Coinbase and Managing Director at Morgan Stanley, as Chief Financial Officer of Streamex. In this role, Ms. Plummer is expected to oversee the Company's global finance organization, including financial reporting, regulatory compliance, and financial operations as Streamex continues expanding its institutional platform and launching tokenized commodity products. Henry McPhie, Co-Founder & CEO of Str

    3/16/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Appoints Shawn Matthews, Former CEO of Cantor Fitzgerald & Co. & Founder and CIO of Hondius Capital Management, to Board of Directors

    WINTER PARK, Fla., March 03, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a leader in institutional-grade tokenization and digital asset infrastructure, today is excited to announce the appointment of Shawn Matthews, Former CEO of Cantor Fitzgerald & Co. and Founder and Chief Investment Officer of Hondius Capital Management, to its Board of Directors. In this role, Mr. Matthews will bring decades of global investment, trading, and executive leadership experience to support Streamex's strategic growth, capital markets initiatives, and governance. He is joining as an independent director. Morgan Lekstrom, Co-Founder & Executive Chairman of Streamex sa

    3/3/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    Financials

    Live finance-specific insights

    View All

    Streamex Corp. Announces June 2026 Yield Dividend Distribution for GLDY

    WINTER PARK, Fla., July 17, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company building the tokenization ecosystem for all real-world assets beginning with commodities, today announced the distribution of the fourth yield payment for GLDY, its yield-bearing gold asset, occurred on July 17th, 2026. The distribution covers the period from June 1st through June 30th, 2026. Yield Distribution Details GLDY's real-world yield is generated through Streamex's institutional gold leasing program, with proceeds from the program distributed to GLDY holders in the form of additional GLDY tokens monthly. Each GLDY token is currently earning an ann

    7/17/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Announces May 2026 Yield Dividend Distribution for GLDY

    WINTER PARK, Fla., June 22, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company building the tokenization ecosystem for all real-world assets beginning with commodities, today announced the distribution of the third yield payment for GLDY, its gold-backed, yield-bearing tokenized security, occurred on June 18th, 2026. The distribution covers the period from May 1st through May 31st, 2026. Yield Distribution Details GLDY's real-world yield is generated through Streamex's institutional gold leasing program, with proceeds from the program distributed to GLDY holders in the form of additional GLDY tokens monthly. Each GLDY token is curren

    6/22/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Provides Q1 2026 Earnings and Corporate Update Presentation Recap; Highlights New Partnerships & Key Updates

    WINTER PARK, Fla., May 21, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company focused on the tokenization of commodity real-world assets, yesterday hosted its Q1 2026 Earnings and Corporate Update Presentation, featuring remarks from Executive Chairman Morgan Lekstrom, Chief Executive Officer Henry McPhie, Chief Financial Officer Christine Plummer, and Chief Investment Officer Mitch Williams. The following is a summary of the key topics covered. Highlights Equity Trust - access to $72B+ and 359,000 U.S. tax-advantaged retirement accounts. An upcoming integration with Equity Trust Company opens GLDY to a distribution channel that prev

    5/21/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care